A Trojan horse approach for efficient drug delivery in photodynamic therapy: focus on taxanes
Language English Country England, Great Britain Media electronic
Document type Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
37615658
DOI
10.1039/d2tb02147a
Knihovny.cz E-resources
- MeSH
- Photochemotherapy * MeSH
- Photosensitizing Agents * pharmacology MeSH
- Drug Delivery Systems MeSH
- Paclitaxel pharmacology MeSH
- Taxoids pharmacology therapeutic use MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Photosensitizing Agents * MeSH
- Paclitaxel MeSH
- Taxoids MeSH
Photodynamic therapy is an effective method for the treatment of several types of cancerous and noncancerous diseases. The key to the success of this treatment method is effective drug delivery to the site of action, for instance, a tumor. This ensures not only the high effectiveness of the therapy but also the suppression of side effects. But how to achieve effective targeted delivery? Lately, much attention has been paid to systems based on the so-called Trojan horse model, which is gaining increasing popularity. The principle of this model is that the effective drug is hidden in the internal structure of a nanoparticle, liposome, or nanoemulsion and is released only at the site of action. In this review article, we focus on drugs from the group of mitotic poisons, taxanes, and their use with photosensitizers in combined therapy. Here, we discuss the possibilities of how to improve the paclitaxel and docetaxel bioavailability, as well as their specific targeting for use in combined photo- and chemotherapy. Moreover, we also present the state of the art multifunctional drugs based on cabazitaxel which, owing to a suitable combination with photosensitizers, can be used besides photodynamic therapy and also in photoacoustic imaging or sonodynamic therapy.
References provided by Crossref.org